Healthcare
Capricorn, Vesalius lead round for Trod
Capricorn Venture Partners and Vesalius Biocapital have co-led a €4.75m series-B funding round for Trod Medical, a Belgian medical devices company.
F-star raises €9.4m from Atlas, Aescap et al.
Biopharmaceutical company F-star has raised тЌ9.4m in a series-A round supported by Altas Venture, Aescap Venture, TVM Capital among others.
Mid Europa's Diagnostyka buys Olympus Consilio
Mid Europa Partners-backed Diagnostyka has acquired Poland-based Olympus Consilio as part of the GP’s consolidation strategy of the laboratory market in the CEE region.
Mid Europa's Alpha Medical buys Euromedic's laboratories
Alpha Medical, a provider of laboratory testing services backed by Mid Europa Partners, has acquired the Czech laboratory business of medical services provider Euromedic.
BC Partners' Aenova acquires Haupt Pharma Gruppe
Aenova, a BC Partners-backed manufacturer of medicines and dietary supplements, has bought a majority stake in pharmaceutical company Haupt Pharma Gruppe.
R Capital's LDR Medical floats on Nasdaq
R Capital Management portfolio company LDR Medical raised $75m in an IPO on the Nasdaq, giving the company a market cap of $489m.
Gimv fully exits Ablynx
Gimv has sold its remaining direct stake of 2.24% in Euronext-listed Ablynx, a Belgian biotechnology company, for €19.1m.
HTGF and Bayern Kapital back Photonics Healthcare
High-Tech Gründerfonds (HTGF) and Bayern Kapital have backed Photonics Healthcare, a medical equipment manufacturer.
GED sells Grupo Sendal, reaps 2x return
GED has sold its stake in healthcare service provider Grupo Sendal to US-based Carefusion and reaped a 2x return.
Auven's ADC Therapeutics receives $40m funding round
Pharmaceuticals company ADC Therapeutics has raised $40m from existing backer Auven Therapeutics and corporation MedImmune.
Auven sells Spirogen in $240m trade sale
Auven Therapeutics has sold cancer drug pharmaceutical company Spirogen to US listed corporation AstraZeneca's subsidiary MedImmune for $240m.
immatics raises €34m series-D financing round
immatics biotechnologies, a biopharmaceutical firm, has raised €34m from existing investors including Wellington Partners and MIG.
Albion invests in Cisiv
Albion Ventures has invested in healthcare software-as-a-service business Cisiv.
Merck could turn to private equity to finance clinical trials
German pharmaceutical company Merck has held talks with private equity firms to potentially finance future clinical trials, according to reports.
Almi Invest backs Peptonic
Venture capital firm Almi Invest has taken a stake in Swedish pharmaceutical company Peptonic.
Almi Invest backs Avalanche Biotech
Almi Invest and business angel PУЄr Ribbner have invested in Swedish life sciences business Avalanche Biotech in exchange for a minority stake in the company.
Doughty's Quirón buys Teknon from Magnum
Magnum Industrial Partners has sold Barcelona-based private medical clinic Centro Médico Teknon to Grupo Hospitalario Quirón, backed by Doughty Hanson, for €225m.
PE backers mull Ceva Santé Animale sale
French veterinary laboratory Ceva Santé Animale, backed by Nixen, Euromezzanine and Sagard, has mandated Lazard to explore the possibility of a sale in the first half of 2014.
Investinor, Industrifonden invest SEK 96m in Pharmalink
Pharmalink has received SEK 96m in a series-C financing round co-led by existing investor Industrifonden and new backer Investinor.
VC-backed Merus secures additional €31m
Dutch biopharma company Merus has received a €31m extension of its 2010 series-B funding round from Johnson & Johnson Development Corporation (JJDC) and its existing venture capital backers.
Omnes injects €3m into Opsona
Omnes Capital has made a capital injection of тЌ3m into immunology drug developer Opsona Therapeutics, in an extension of the companyтs series-C round.
Avista and Nordic Capital make tender offer for Acino
Avista Capital Partners and Nordic Capital have made a public tender offer for pharmaceutical company Acino.
Sherpa Capital buys Grupo Indo
Spanish turnaround investor Sherpa Capital has made a binding offer to acquire the production unit of ophthalmic lenses company Grupo Indo, after it hit bankruptcy in 2010.
VCs keep finger on the pulse of healthcare tech
Healthcare tech